Yipinhong Pharmaceutical Co Ltd Class A (300723) — Net Asset Momentum
Yipinhong Pharmaceutical Co Ltd Class A (300723) recorded a net asset momentum of -27.3% as of December 2025, with net assets of CN¥1.41 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Yipinhong Pharmaceutical Co Ltd Class A to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Yipinhong Pharmaceutical Co Ltd Class A Net Asset Momentum (2013–2025)
This chart tracks Yipinhong Pharmaceutical Co Ltd Class A's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is -27.3%, with net assets of CN¥1.41 Billion CNY as of December 2025. Read total liabilities of Yipinhong Pharmaceutical Co Ltd Class A for a breakdown of total debt and financial obligations.
Annual Net Asset History for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
The table below shows the complete annual net asset history for Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Yipinhong Pharmaceutical Co Ltd Class A (300723) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.41 Billion | CN¥4.04 Billion | CN¥2.64 Billion | ▼ -27.3% |
| 2024 | CN¥1.94 Billion | CN¥4.40 Billion | CN¥2.47 Billion | ▼ -25.5% |
| 2023 | CN¥2.60 Billion | CN¥4.41 Billion | CN¥1.81 Billion | ▲ +20.0% |
| 2022 | CN¥2.17 Billion | CN¥4.10 Billion | CN¥1.93 Billion | ▲ +7.3% |
| 2021 | CN¥2.02 Billion | CN¥3.70 Billion | CN¥1.69 Billion | ▲ +35.0% |
| 2020 | CN¥1.50 Billion | CN¥2.15 Billion | CN¥650.14 Million | ▲ +11.5% |
| 2019 | CN¥1.34 Billion | CN¥1.79 Billion | CN¥454.20 Million | ▲ +3.2% |
| 2018 | CN¥1.30 Billion | CN¥1.78 Billion | CN¥481.67 Million | ▲ +17.2% |
| 2017 | CN¥1.11 Billion | CN¥1.48 Billion | CN¥373.45 Million | ▲ +229.4% |
| 2016 | CN¥336.50 Million | CN¥752.32 Million | CN¥415.82 Million | ▲ +67.7% |
| 2015 | CN¥200.66 Million | CN¥630.56 Million | CN¥429.90 Million | ▲ +57.3% |
| 2014 | CN¥127.52 Million | CN¥733.80 Million | CN¥606.28 Million | ▼ -31.3% |
| 2013 | CN¥185.61 Million | CN¥411.27 Million | CN¥225.66 Million | — |